Enzo Debt Ratio from 2010 to 2024

ENZ Stock

USD 1.08 0.05 4.85%

Enzo Biochem Debt Ratio yearly trend continues to be fairly stable with very little volatility. Debt Ratio will likely drop to 0 in 2024. During the period from 2010 to 2024, Enzo Biochem Debt Ratio regression line of annual values had r-squared of 0.17 and arithmetic mean of 0.08. View All Fundamentals

Debt Ratio

First Reported

2010-12-31

Previous Quarter

0.00308987

Current Value

0.002935

Quarterly Volatility

0.15987987

Credit Downgrade

Yuan Drop

Covid

Check Enzo Biochem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enzo Biochem's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.5 M, Interest Expense of 187.2 K or Total Revenue of 63.1 M, as well as many indicators such as Price To Sales Ratio of 1.73, Dividend Yield of 2.0E-4 or PTB Ratio of 0.98. Enzo financial statements analysis is a perfect complement when working with Enzo Biochem Valuation or Volatility modules.

Check out the analysis of Enzo Biochem Correlation against competitors.

For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

Latest Enzo Biochem's Debt Ratio Growth Pattern

Below is the plot of the Debt Ratio of Enzo Biochem over the last few years. It is Enzo Biochem's Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Enzo Biochem's overall financial position and show how it may be relating to other accounts over time.

Debt Ratio

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Debt Ratio

Timeline

Enzo Debt Ratio Regression Statistics

	Arithmetic Mean	0.08
	Geometric Mean	0.01
	Coefficient Of Variation	199.00
	Mean Deviation	0.08
	Median	0.04
	Standard Deviation	0.16
	Sample Variance	0.03
	Range	0.6401
	R-Value	(0.41)
	Mean Square Error	0.02
	R-Squared	0.17
	Significance	0.13
	Slope	(0.01)
	Total Sum of Squares	0.36

Enzo Debt Ratio History

	2024	0.002935
	2023	0.00309
	2022	0.0362
	2021	0.0872
	2020	0.0704
	2019	0.14
	2018	0.0405

Other Fundumenentals of Enzo Biochem

Cash Flow To Debt Ratio

Enzo Biochem Debt Ratio component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Accounts Payable	Short Term Debt	Common Stock	Good Will	Property Plant Equipment	Short Term Investments	Current Deferred Revenue	Long Term Debt	Net Tangible Assets	Capital Surpluse	Short Long Term Debt	Long Term Debt Total	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.83	-0.54	-0.15	-0.18	0.23	0.9	-0.59	0.01	0.1	0.47	0.0	0.47	0.14	-0.44	0.37	0.79	0.41	-0.35	0.42	-0.3	-0.28	-0.44	0.24
Total Stockholder Equity	0.83		-0.77	-0.33	0.17	-0.34	0.87	-0.38	0.25	-0.2	0.58	-0.09	0.24	-0.14	-0.4	0.09	0.84	0.37	-0.58	0.16	-0.1	-0.08	-0.12	0.18
Net Debt	-0.54	-0.77		0.14	-0.05	0.44	-0.8	0.1	-0.02	0.49	-0.37	0.12	0.2	0.49	0.24	0.41	-0.78	-0.39	0.4	0.35	-0.5	-0.07	-0.19	-0.25
Retained Earnings	-0.15	-0.33	0.14		-0.38	0.33	-0.01	-0.33	-0.34	-0.27	-0.9	0.49	-0.41	0.38	-0.39	-0.22	-0.2	-0.42	0.16	-0.16	0.19	0.35	0.35	-0.28
Net Receivables	-0.18	0.17	-0.05	-0.38		-0.54	-0.12	0.07	0.92	0.15	0.28	-0.31	-0.21	-0.21	0.15	-0.12	-0.16	-0.42	0.12	-0.08	0.17	0.6	0.55	-0.61
Total Liab	0.23	-0.34	0.44	0.33	-0.54		0.01	-0.35	-0.36	0.53	-0.2	0.05	0.39	0.49	-0.03	0.49	-0.12	0.01	0.43	0.45	-0.31	-0.28	-0.48	-0.01
Total Current Assets	0.9	0.87	-0.8	-0.01	-0.12	0.01		-0.54	-0.01	-0.21	0.39	-0.07	0.21	-0.01	-0.48	0.01	0.9	0.42	-0.45	0.08	0.06	-0.09	-0.12	0.2
Intangible Assets	-0.59	-0.38	0.1	-0.33	0.07	-0.35	-0.54		-0.09	-0.18	0.01	-0.11	-0.24	-0.47	0.84	-0.44	-0.42	-0.09	0.14	-0.51	0.33	0.0	0.17	0.16
Accounts Payable	0.01	0.25	-0.02	-0.34	0.92	-0.36	-0.01	-0.09		0.33	0.29	-0.32	-0.09	-0.11	0.02	0.08	-0.1	-0.49	0.18	0.12	0.03	0.58	0.43	-0.71
Short Term Debt	0.1	-0.2	0.49	-0.27	0.15	0.53	-0.21	-0.18	0.33		0.18	-0.14	0.4	0.27	0.08	0.55	-0.28	-0.12	0.65	0.5	-0.34	-0.11	-0.35	-0.15
Common Stock	0.47	0.58	-0.37	-0.9	0.28	-0.2	0.39	0.01	0.29	0.18		-0.62	0.54	-0.29	0.16	0.3	0.55	0.59	-0.34	0.27	-0.18	-0.39	-0.41	0.27
Good Will	0.0	-0.09	0.12	0.49	-0.31	0.05	-0.07	-0.11	-0.32	-0.14	-0.62		-0.36	0.18	-0.24	-0.12	-0.31	-0.32	0.06	-0.11	-0.21	0.07	0.02	0.16
Property Plant Equipment	0.47	0.24	0.2	-0.41	-0.21	0.39	0.21	-0.24	-0.09	0.4	0.54	-0.36		0.56	-0.03	0.63	0.36	0.49	-0.31	0.6	-0.61	-0.52	-0.63	0.33
Short Term Investments	0.14	-0.14	0.49	0.38	-0.21	0.49	-0.01	-0.47	-0.11	0.27	-0.29	0.18	0.56		-0.31	0.33	-0.06	-0.1	-0.12	0.34	-0.53	-0.03	-0.14	-0.06
Current Deferred Revenue	-0.44	-0.4	0.24	-0.39	0.15	-0.03	-0.48	0.84	0.02	0.08	0.16	-0.24	-0.03	-0.31		-0.18	-0.45	-0.13	0.3	-0.25	0.19	0.02	0.07	-0.01
Long Term Debt	0.37	0.09	0.41	-0.22	-0.12	0.49	0.01	-0.44	0.08	0.55	0.3	-0.12	0.63	0.33	-0.18		0.04	0.07	0.04	0.99	-0.71	-0.3	-0.6	-0.09
Net Tangible Assets	0.79	0.84	-0.78	-0.2	-0.16	-0.12	0.9	-0.42	-0.1	-0.28	0.55	-0.31	0.36	-0.06	-0.45	0.04		0.69	-0.62	0.1	0.02	-0.32	-0.26	0.39
Capital Surpluse	0.41	0.37	-0.39	-0.42	-0.42	0.01	0.42	-0.09	-0.49	-0.12	0.59	-0.32	0.49	-0.1	-0.13	0.07	0.69		-0.49	0.04	-0.12	-0.79	-0.63	0.82
Short Long Term Debt	-0.35	-0.58	0.4	0.16	0.12	0.43	-0.45	0.14	0.18	0.65	-0.34	0.06	-0.31	-0.12	0.3	0.04	-0.62	-0.49		0.0	0.29	0.31	0.16	-0.38
Long Term Debt Total	0.42	0.16	0.35	-0.16	-0.08	0.45	0.08	-0.51	0.12	0.5	0.27	-0.11	0.6	0.34	-0.25	0.99	0.1	0.04	0.0		-0.7	-0.25	-0.55	-0.13
Cash And Equivalents	-0.3	-0.1	-0.5	0.19	0.17	-0.31	0.06	0.33	0.03	-0.34	-0.18	-0.21	-0.61	-0.53	0.19	-0.71	0.02	-0.12	0.29	-0.7		0.52	0.69	-0.15
Net Invested Capital	-0.28	-0.08	-0.07	0.35	0.6	-0.28	-0.09	0.0	0.58	-0.11	-0.39	0.07	-0.52	-0.03	0.02	-0.3	-0.32	-0.79	0.31	-0.25	0.52		0.92	-0.78
Net Working Capital	-0.44	-0.12	-0.19	0.35	0.55	-0.48	-0.12	0.17	0.43	-0.35	-0.41	0.02	-0.63	-0.14	0.07	-0.6	-0.26	-0.63	0.16	-0.55	0.69	0.92		-0.6
Capital Stock	0.24	0.18	-0.25	-0.28	-0.61	-0.01	0.2	0.16	-0.71	-0.15	0.27	0.16	0.33	-0.06	-0.01	-0.09	0.39	0.82	-0.38	-0.13	-0.15	-0.78	-0.6

Click cells to compare fundamentals

About Enzo Biochem Financial Statements

Enzo Biochem investors use historical fundamental indicators, such as Enzo Biochem's Debt Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Enzo Biochem. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Cash Flow To Debt Ratio	(99.09)	(104.05)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Enzo Stock Analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Enzo Debt Ratio from 2010 to 2024

Latest Enzo Biochem's Debt Ratio Growth Pattern

Enzo Debt Ratio Regression Statistics

Enzo Debt Ratio History

Other Fundumenentals of Enzo Biochem

Enzo Biochem Debt Ratio component correlations

About Enzo Biochem Financial Statements

Also Currently Popular

Additional Tools for Enzo Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY